by Ashley Wilcox | Sep 23, 2021 | News
Congratulations to ONDRI’s co-lead Dr. Mario Masellis and the rest of the contributors to this important report. The World Azheimer Report 2021 focuses on the crucial and timely subject of diagnosis. Dr. Masellis’ contribution delves specifically into...
by Ashley Wilcox | Sep 14, 2021 | News
Queen’s University distinguished professor, researcher and ONDRI co-lead Doug Munoz, PhD has been elected to the Canadian Academy of Health Sciences (CAHS) Fellowship, one of Canada’s premier academic honours. Munoz is joined in this honour this year, by distinguished...
by Ruth Kruger | Aug 12, 2021 | News
Aducanumab, a possible treatment, or disease-modifying therapy, for Alzheimer’s disease (AD), developed by Biogen, is under evaluation for approval by Health Canada (HC). This follows its conditional approval by FDA in the United States, amidst significant...
by Ashley Wilcox | Aug 6, 2021 | News
The 2021 AAIC conference took place on July 26-30, 2021, in Denver, Colorado and concurrently as a virtual event. This annual conference is an opportunity to showcase important research in Alzheimer’s disease and dementia from around the world. This year, work...
by Ruth Kruger | May 14, 2021 | News
Dr. Richard Swartz, ONDRI co-lead, will be presenting his research on the complex impacts of COVID-19 on stroke risk, care and outcomes at the International Dementia Symposium, May 18-19, 2021. For more information on this study click here. ONDRI...
by Ashley Wilcox | Apr 14, 2021 | News
ONDRI researchers have co-authored a paper highlighting promising new potential Parkinson’s Disease (PD) biomarkers (or early indicators of disease). Doug Munoz, Julia Perkins, Brian Coe, Jeff Huang and Donald Brien – working out of Centre for Neuroscience...
